An interview with Steven C. Borkan, M.D., Associate Professor of Medicine at BU, and Attending Physician at Boston Medical Center. The following discussion with Dr. Steven C. Broken took place at our BU Innovator of the Year Award event — where he explained his focus on treating acute kidney injury, his ideas on invention vs. […]
Are you working on an idea to impact a customer, audience, or market? (Since we have policy people in the audience whose “market” is the government, let’s define “market” as the audience you wish to adopt your idea.) Whether you plan to start a company, license to a third party, or collaborate with the government […]
April 2022 | News from BU Industry Engagement and Technology Development Spotlight Photonics Pioneer Named BU Innovator of the Year Professor Selim Ünlü, Electrical & Computer Engineering (ENG), has pioneered devices and technologies that find security flaws in the construction of computer chips and detect viral pathogens in medical samples. Ünlü holds 18 patents and […]
Following is a brief case study on Passport Systems, an MIT spinout which had to shut its doors in 2020 after a nearly 20 years’ effort and $100M invested. I wrote this case study with the assistance of Dr. Gordon Baty, a former colleague who was Chairman and Co-Founder of Passport, with the hope that […]
Dr. Selim Ünlü, Professor of Electrical & Computer Engineering (ENG), was named 2021 BU Innovator of the Year for his pioneering work developing devices and technologies that help find security flaws in the construction of computer chips and detect viral pathogens in medical samples. Ünlü holds 18 patents and has helped launch three companies, all […]
Many of our researchers and faculty at BU are doing work to make real change in the world. As part of our series of discussions with faculty innovators, I speak with Professor Ji-Xin Cheng, Moustakas Chair Professor in Photonics and Optoelectronics and Professor of Biomedical Engineering (ENG). Professor Cheng’s research pursues a wide range of topics, including […]
In February, the Office of Research hosted an event called The Lab to Market Transition: Lessons from Faculty, Students, and Other Research Staff. The event highlighted scenarios in which post grads spun out companies with the technology they worked on in their PI’s lab. We had four spinout guests, at different stages of maturity, with […]
November 2021 | News from BU Industry Engagement and Technology Development Spotlight Microbiologist Robert Davey and his team research the novel coronavirus wearing full biocontainment suits in the highest possible containment setting, the Biosafety Level 4 lab at BU’s National Emerging Infectious Diseases Laboratories (NEIDL). How BU’s NEIDL Increased Industry Support Four-Fold In 2020, NEIDL […]
This fall we launched a new program titled “Invasion of the Equity Investors.” I specifically named the investors “equity investors” to ensure there’s no mistake about the nature of the transaction in the offing. Equity investors (Angels and venture capitalists) purchase shares in your company in return for cash. The ‘”invasion” was chosen to attract attention, or perhaps make you smile. They are one source of funding. There are many, many additional and alternative forms of funding besides equity (click here for a posted presentation on the subject), but that’s a conversation for another day. We had three investors scheduled thus far this semester. One more will listen to pitches on November 4. We’ll be inviting more next semester.
Here’s a misunderstood word: commercialization. The University of Pittsburgh offers a straightforward definition: “Commercialization is the process by which a new product or service is introduced into the general market.” That’s it. Too often, commercialization is misunderstood to mean “sales and marketing.” Those tasks are components of commercialization; they are not synonymous with the word. I suppose it’s because commerce is the root of commercialization so people’s minds go right to the transaction side of business (sales and marketing).